Cases and Conversations™: Mineralocorticoid Receptor Antagonists in Patients With HF—Augmenting Current Guidelines with Emerging Evidence

Summary: Heart failure is a huge challenge, but doctors have a powerful tool to help: medicines called MRAs (mineralocorticoid receptor antagonists). These drugs are game-changers because they keep patients out of the hospital, help them live longer, and improve their daily lives. A new training program teaches doctors and nurses how to pick the right MRA—whether it's the older steroidal kind or the newer non-steroidal type—for different types of heart failure. It also covers how to safely manage side effects like high potassium levels. By learning these skills, healthcare workers can create the best personalized treatment plans for their patients, all while earning their required continuing education credits.

For more details, see rssapp-patientcareonline-com at gotoper.com/courses/cases-and-conversations-mineralocorticoid-receptor-antagonists-in-patients-with-hfaugmenting-current-guidelines-with-emerging-evidence (opens in new tab)